Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 12, 2003

View Archived Issues

Company Profile: Transition Therapeutics

Genzyme to acquire SangStat

Akina develops oral drug delivery technology

Two novel series of VR1 antagonists for urinary incontinence, pain, etc.

Galderma presents new PPARgamma agonists with potential in dermatological disorders

BMS claims new IMPDH inhibitors and their use in recent patent

Aventis scientists prepare new antibacterial streptogramin derivatives

Novel alpha7 nAChR agonists in early development at Bayer

New MMP, TACE and/or aggrecanase inhibitors covered by BMS patent

R&D highlights at Neurosearch

Once-daily Adderall XR formulation may be a useful treatment option in children with ADHD

FTC clears Biogen/Idec merger

NexMed enters NexACT R&D agreement for asthma

Novel 5-HT7 receptor agonist modulates REM sleep

Human Genome Sciences and Genentech enter licensing agreement

17-AAG combination regimens studied in new phase Ib trials

Neurosciences Australia and CSIRO form R&D partnership in brain disorders

First pivotal exenatide study produces positive results

MPC-7869 reduces Abeta42 levels more effectively than select NSAIDs

Exelixis reports quarterly progress

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...